Literature DB >> 30535531

Expression profile of long non-coding RNAs in rat models of OSA-induced cardiovascular disease: new insight into pathogenesis.

Qingshi Chen1,2, Guofu Lin1,3,4, Jiefeng Huang1,3,4, Gongping Chen1,3,4, Xiaoyun Huang1,3,4, Qichang Lin5,6,7.   

Abstract

PURPOSE: Long non-coding RNAs (lncRNAs) are a recently identified class of regulatory molecules involved in the regulation of numerous biological processes, but their functions in a rat model of chronic intermittent hypoxia (CIH) remain largely unknown. Therefore, for further investigation, we aimed to explore lncRNA expression profiles and reveal their potential functional roles in rat models of CIH.
METHODS: We used a well-established CIH rat model and conducted lncRNA microarray experiments on the heart samples of rats with CIH and under normoxia control. Differentially expressed lncRNAs and mRNAs were identified via fold-change filtering and verified by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Bioinformatics analyses were applied to reveal the potential roles of key lncRNAs. Co-expression analysis was conducted to determine the transcriptional regulatory relationship of lncRNAs and mRNAs between the two groups.
RESULTS: Our data indicated that 157 lncRNAs and 319 mRNAs were upregulated, while 132 lncRNAs and 428 mRNAs were downregulated in the rat model of CIH compared with sham control. Pathway analyses showed that 31 pathways involved in upregulated transcripts and 28 pathways involved in downregulated transcripts. Co-expression networks were also constructed to explore the potential roles of differentially expressed lncRNAs on mRNAs. LncRNAs, namely, XR_596701, XR_344474, XR_600374, ENSRNOT00000065561, XR_590196, and XR_597099, were validated by the use of qRT-PCR.
CONCLUSIONS: The present study first revealed lncRNAs expression profiles in a rat model of CIH, providing new insight into the pathogenesis of obstructive sleep apnea-induced cardiovascular disease.

Entities:  

Keywords:  Cardiovascular disease; Expression profiles; Long non-coding RNA; Obstructive sleep apnea

Mesh:

Substances:

Year:  2018        PMID: 30535531     DOI: 10.1007/s11325-018-1753-0

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.655


  24 in total

1.  Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

Authors:  R Schulz; S Mahmoudi; K Hattar; U Sibelius; H Olschewski; K Mayer; W Seeger; F Grimminger
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

Review 2.  Obstructive sleep apnoea and its cardiovascular consequences.

Authors:  T Douglas Bradley; John S Floras
Journal:  Lancet       Date:  2008-12-26       Impact factor: 79.321

3.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

4.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

Authors:  E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

5.  Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

6.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.

Authors:  Larissa Dyugovskaya; Peretz Lavie; Lena Lavie
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

8.  Changes in extracranial arteries in obstructive sleep apnoea.

Authors:  R Schulz; W Seeger; C Fegbeutel; H Hüsken; R H Bödeker; H Tillmanns; M Grebe
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

9.  Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension.

Authors:  Elizabeth S Muxfeldt; Victor S Margallo; Gleison M Guimarães; Gil F Salles
Journal:  Am J Hypertens       Date:  2014-04-04       Impact factor: 2.689

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  9 in total

1.  Long non-coding RNA MALAT1 affects intermittent hypoxia-induced endothelial injury by regulating miR-142-3p/HMGB1.

Authors:  Meng-Xue Chen; Li-Da Chen; Jian-Chai Huang; Ai-Ming Zeng; Jie-Feng Huang; Qi-Chang Lin
Journal:  Sleep Breath       Date:  2022-01-10       Impact factor: 2.816

2.  LncRNA XR_595552 inhibition alleviates intermittent hypoxia-induced cardiomyocyte damage via activating the PI3K/AKT pathway.

Authors:  Qingshi Chen; Dandan Guo; Guofu Lin; Mengxue Chen; Jiefeng Huang; Qichang Lin
Journal:  Sleep Breath       Date:  2022-02-23       Impact factor: 2.816

Review 3.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

4.  Decreased expression of PPARγ is associated with aortic endothelial cell apoptosis in intermittently hypoxic rats.

Authors:  Ningfang Lian; Mengxue Chen; Shuyi Zhang; Lida Chen; Jiefeng Huang; Qichang Lin
Journal:  Sleep Breath       Date:  2021-03-10       Impact factor: 2.816

5.  MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Diguang Pan; Guiyong Liu; Bin Li; Jingbo Jiang; Wei Chen; Wei Li; Lin Zhang; Yubao Hu; Shuyun Xie; Huayun Yang
Journal:  Pflugers Arch       Date:  2021-01-08       Impact factor: 3.657

6.  TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats.

Authors:  Zhi-Peng Lin; Hui-Li Lin; Xue-Ping Yu; Yi-Juan Zheng; Si-Yu Cheng
Journal:  Mol Med Rep       Date:  2020-05-07       Impact factor: 2.952

7.  LncRNA XR_596701 protects H9c2 cells against intermittent hypoxia-induced injury through regulation of the miR-344b-5p/FAIM3 axis.

Authors:  Qingshi Chen; Guofu Lin; Lanlan Lin; Jiefeng Huang; Lida Chen; Ningfang Lian; Mengxue Chen; Aiming Zeng; Qichang Lin
Journal:  Cell Death Discov       Date:  2022-01-28

8.  Screening of plasma exosomal lncRNAs to identify potential biomarkers for obstructive sleep apnea.

Authors:  Xunxun Chen; Hongbing Liu; Rong Huang; Ran Wei; Yuchuan Zhao; Taoping Li
Journal:  Ann Transl Med       Date:  2022-09

9.  Impact of chronic intermittent hypoxia on the long non-coding RNA and mRNA expression profiles in myocardial infarction.

Authors:  Chaowei Hu; Jing Li; Yunhui Du; Juan Li; Yunyun Yang; Yifan Jia; Lu Peng; Yanwen Qin; Yongxiang Wei
Journal:  J Cell Mol Med       Date:  2020-11-20       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.